881 related articles for article (PubMed ID: 25739660)
1. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
Zhang A; Sun H; Yan G; Wang P; Wang X
Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
[TBL] [Abstract][Full Text] [Related]
2. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
[TBL] [Abstract][Full Text] [Related]
3. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis.
Zhang AH; Sun H; Qiu S; Wang XJ
Magn Reson Chem; 2013 Sep; 51(9):549-56. PubMed ID: 23828598
[TBL] [Abstract][Full Text] [Related]
4. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies.
Wang X; Sun H; Zhang A; Wang P; Han Y
J Sep Sci; 2011 Dec; 34(24):3451-9. PubMed ID: 21826791
[TBL] [Abstract][Full Text] [Related]
5. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach.
Zhang A; Sun H; Han Y; Yuan Y; Wang P; Song G; Yuan X; Zhang M; Xie N; Wang X
Analyst; 2012 Sep; 137(18):4200-8. PubMed ID: 22852134
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics study of intervention effects of Wen-Xin-Formula using ultra high-performance liquid chromatography/mass spectrometry coupled with pattern recognition approach.
Wang X; Wang Q; Zhang A; Zhang F; Zhang H; Sun H; Cao H; Zhang H
J Pharm Biomed Anal; 2013 Feb; 74():22-30. PubMed ID: 23245229
[TBL] [Abstract][Full Text] [Related]
7. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics for Biomarker Discovery: Moving to the Clinic.
Zhang A; Sun H; Yan G; Wang P; Wang X
Biomed Res Int; 2015; 2015():354671. PubMed ID: 26090402
[TBL] [Abstract][Full Text] [Related]
10. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
Gika HG; Theodoridis GA; Plumb RS; Wilson ID
J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
[TBL] [Abstract][Full Text] [Related]
11. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
12. PAIRUP-MS: Pathway analysis and imputation to relate unknowns in profiles from mass spectrometry-based metabolite data.
Hsu YH; Churchhouse C; Pers TH; Mercader JM; Metspalu A; Fischer K; Fortney K; Morgen EK; Gonzalez C; Gonzalez ME; Esko T; Hirschhorn JN
PLoS Comput Biol; 2019 Jan; 15(1):e1006734. PubMed ID: 30640898
[TBL] [Abstract][Full Text] [Related]
13. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
14. High resolution mass spectrometry based techniques at the crossroads of metabolic pathways.
Junot C; Fenaille F; Colsch B; Bécher F
Mass Spectrom Rev; 2014; 33(6):471-500. PubMed ID: 24288070
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics approach based on utra-performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high-throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction.
Zhao LK; Zhao YB; Yu PC; Zhang PX
Biomed Chromatogr; 2020 Aug; 34(8):e4847. PubMed ID: 32285481
[TBL] [Abstract][Full Text] [Related]
16. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.
Zhao YY; Lin RC
Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021
[TBL] [Abstract][Full Text] [Related]
17. Rapidly improved determination of metabolites from biological data sets using the high-efficient TransOmics tool.
Zhang A; Zhou X; Zhao H; Guan Y; Zou S; Yan GL; Ma CW; Liu Q; Wang X
Mol Biosyst; 2014 Aug; 10(8):2160-5. PubMed ID: 24889752
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics and proteomics technologies to explore the herbal preparation affecting metabolic disorders using high resolution mass spectrometry.
Zhang A; Zhou X; Zhao H; Zou S; Ma CW; Liu Q; Sun H; Liu L; Wang X
Mol Biosyst; 2017 Jan; 13(2):320-329. PubMed ID: 28045158
[TBL] [Abstract][Full Text] [Related]
19. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
[TBL] [Abstract][Full Text] [Related]
20. CE-MS in metabolomics.
Ramautar R; Somsen GW; de Jong GJ
Electrophoresis; 2009 Jan; 30(1):276-91. PubMed ID: 19107702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
